Origin Endoscopy


Origin Endoscopy is an early-stage med-tech company focused on more effective solutions to control gastrointestinal (GI) bleeding. Founded through collaboration between Johns Hopkins Medicine and the University of Maryland, the company develops innovative technologies, including a durable gel to manage GI bleeding and promote healing, aiming to improve patient outcomes and reduce costs.

Industries

biopharma
biotechnology
medical

Nr. of Employees

small (1-50)

Origin Endoscopy

Englewood, Colorado, United States, North America


Products

Sustained-release epinephrine hydrogel for endoscopic hemostasis

A hydrogel formulation incorporating sustained-release epinephrine microparticles intended for rapid bio-adhesion and submucosal injection to achieve hemostasis during endoscopic procedures.


Services

Conducting and finalizing safety and efficacy studies to evaluate a hydrogel-based hemostatic product and associated delivery device.

Design and prototype development of a device intended to deliver a bio-adhesive hydrogel formulation during endoscopy.

Expertise Areas

  • Therapeutic endoscopy
  • Hemostasis and gastrointestinal bleeding management
  • Biomaterial hydrogel formulation
  • Drug–device combination development
  • Show More (3)

Key Technologies

  • Sustained-release drug-loaded microparticles
  • Bio-adhesive hydrogel formulations
  • Endoscopic delivery devices
  • Submucosal injection delivery methods
  • Show More (1)

News & Updates

Origin Endoscopy Wins ASGE Innovation Award and Secures Investment from Innosphere Ventures Fund and Highpoint Ventures

Origin Endoscopy, an early-stage med tech company, won the ASGE Innovation Award for their sustained-release epinephrine gel technology. The award will be presented at the DDW conference. The company was formed through collaboration of inventors from Johns Hopkins Medicine and the University of Maryland, and commercial experts. Their primary technology, developed by Dr. Venkata Akshintala and Dr. Stephen Hoag, aims to control and extend the hemostatic effects of GI bleeding during endoscopy procedures. The company received investment support from Innosphere Ventures and Highpoint Ventures to finalize safety and efficacy studies and develop prototypes.

Origin Endoscopy Wins ASGE Innovation Award and Secures Investment from Innosphere Ventures Fund and Highpoint Ventures

Origin Endoscopy, an early-stage med tech company, won the ASGE Innovation Award for their sustained-release epinephrine gel technology. The award will be presented at the DDW conference. The company was formed through collaboration of inventors from Johns Hopkins Medicine and the University of Maryland, and commercial experts. Their primary technology, developed by Dr. Venkata Akshintala and Dr. Stephen Hoag, aims to control and extend the hemostatic effects of GI bleeding during endoscopy procedures. The company received investment support from Innosphere Ventures and Highpoint Ventures to finalize safety and efficacy studies and develop prototypes.

Exciting news! We are thrilled to announce a remarkable achievement from one of our esteemed portfolio companies at Innosphere Ventures Fund.

Dr. Venkata Akshintala, representing ASGE, has won this year's prestigious shark tank trophy for his innovative product designed to address post-GI procedure bleeding. Dr. Akshintala is also the acting Chief Medical Officer of Origin, a company resulting from collaborations between Monarc Partners, University of Maryland, and Johns Hopkins.

ASGE Innovation Award

Origin Endoscopy won the prestigious American Society for Gastrointestinal Endoscopy (ASGE) Innovation Award for their novel sustained-release epinephrine gel technology.

Shark Tank Trophy at ASGE

Dr. Venkata Akshintala, representing ASGE, won the shark tank trophy for his innovative product to address post-GI procedure bleeding.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.